Hla mAb (Integrated BioTherapeutics)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameHla mAb (Integrated BioTherapeutics)
Drug Alias Namealpha hemolysin mAb (Integrated BioTherapeutics)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAlpha-hemolysin modulators
TargetsAlpha-hemolysin
Therapy Area/IndicationsStaphylococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIntegrated Biotherapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIntegrated Biotherapeutics
Active IndicationsN/A
Inactive IndicationsStaphylococcal Infections

Other Information

ATC CodeN/A
Related LinksN/A